These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11039852)

  • 1. Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy.
    Shtrasburg S; Pras M; Dolitzky M; Pariente C; Gal R; Livneh A
    J Lab Clin Med; 2000 Oct; 136(4):314-9. PubMed ID: 11039852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen.
    Shtrasburg S; Pras M; Gal R; Salai M; Livneh A
    J Lab Clin Med; 2001 Aug; 138(2):107-11. PubMed ID: 11477377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of amyloidogenesis in a mouse model by corticosteroid intervention.
    Shtrasburg S; Lidar M; Pras M; Pariente C; Gal R; Livneh A
    Transl Res; 2007 Jul; 150(1):66-72. PubMed ID: 17585865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis.
    Shtrasburg S; Pras M; Brezniak N; Dolitzki M; Livneh A
    J Lab Clin Med; 1999 Aug; 134(2):168-72. PubMed ID: 10444031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts at suppression of amyloidogenesis in a mouse model by a variety of anti-inflammatory agents.
    Shtrasburg S; Pras M; Rabinovich E; Gal R; Livneh A; Lidar M
    Autoimmun Rev; 2012 Nov; 12(1):18-21. PubMed ID: 22878271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
    Snow AD; Kisilevsky R
    Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of amyloid enhancing factor: clinical and experimental implications.
    Shtrasburg S; Pras M; Brezniak N; Livneh A
    Clin Exp Rheumatol; 1998; 16(3):299-302. PubMed ID: 9631753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.
    Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P
    Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased propensity for amyloidogenesis in male mice.
    Shtrasburg S; Pras M; Dulitzky M; Pariente C; Gal R; Mor A; Livneh A
    Clin Exp Rheumatol; 2004; 22(4):421-6. PubMed ID: 15301238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely active murine amyloid enhancing factor.
    Shtrasburg S; Livneh A; Gal R; Pras M
    Clin Exp Rheumatol; 1996; 14(1):37-42. PubMed ID: 8697655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of amyloid enhancing factor and its biological properties in murine alveolar hydatidosis.
    Abankwa GV; Ali-Khan Z
    Br J Exp Pathol; 1988 Feb; 69(1):123-32. PubMed ID: 3348956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.